Relaxed complex scheme and molecular dynamics simulation suggests small molecule inhibitor of human TMPRSS2 for combating COVID-19

Relaxed complex scheme and molecular dynamics simulation suggests small molecule inhibitor of human TMPRSS2 for combating COVID-19

As the coronavirus disease 19 (COVID-19) pandemic continues to pose a health and economic crisis worldwide, the quest for drugs and/or vaccines against the virus continues. The human transmembrane protease serine 2 (TMPRSS2) has attracted attention as a target for drug discovery, as inhibition of it...

Full description

Saved in:
Bibliographic Details
Published in:Journal of biomolecular structure & dynamics Vol. 40; no. 24; pp. 13925 - 13935
Main Authors: Vuai, Said A. H., Ogedjo, Marcelina M., Isaac, Onoka, Sahini, Mtabazi G., Swai, Hulda S., Shadrack, Daniel M.
Format: Journal Article
Language:English
Published: England Taylor & Francis 01-01-2022
Subjects:
Antiviral Agents - pharmacology
Catalysis
COVID-19
ensemble structure
Humans
Molecular Docking Simulation
molecular dynamics
Molecular Dynamics Simulation
Protease Inhibitors - pharmacology
SARS-COV-2
Serine Endopeptidases
virtual screening
COVID-19
virtual screening
molecular dynamics
SARS-COV-2
ensemble structure
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:As the coronavirus disease 19 (COVID-19) pandemic continues to pose a health and economic crisis worldwide, the quest for drugs and/or vaccines against the virus continues. The human transmembrane protease serine 2 (TMPRSS2) has attracted attention as a target for drug discovery, as inhibition of its catalytic reaction would result in the inactivation of the proteolytic cleavage of the SARS-CoV-2 S protein. As a result, the inactivation prevents viral cell entry to the host's cell. In this work, we screened and identified two potent molecules that interact and inhibit the catalytic reaction by using computational approaches. Two docking screening experiments were performed utilizing the crystal structure and holo ensemble structure obtained from molecular dynamics in bound form. There is enhancement and sensitivity of docking results to the holo ensemble as compared to the crystal structure. Compound 1 demonstrated a similar inhibition value to nafamostat by interacting with catalytic triad residues His296 and Ser441, thereby disrupting the already established hydrogen bond interaction. The stability of the ligand-TMPRSS2 complexes was studied by molecular dynamics simulation, and the binding energy was re-scored by using molecular mechanics Poisson-Boltzmann surface area (MM-PBSA) binding free energy. The obtained compounds may serve as an initial point toward the discovery of potent TMPRSS2 inhibitors upon further in vivo validation. Communicated by Ramaswamy H. Sarma
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ISSN:0739-1102
1538-0254
DOI:10.1080/07391102.2021.1997817